drugset / Trial / NCT01358383

Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers

NCT01358383

Phase 1 Completed 28 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This is an assessment of Pharmacokinetics of a single oral dose of VIMOVO in healthy adult volunteers.

Timeline

Start
2011-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg Oral
Subject Naproxen Small molecule 250 mg Oral